SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Amarin Corp. PLC ADS (AMRN)

AMRN RSS Feed
Add AMRN Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Dancing in the dark, go seek, investorfreak69, Biobillionair, HDGabor
Search This Board:
Last Post: 2/28/2015 3:33:36 PM - Followers: 288 - Board type: Free - Posts Today: 73

Amarin Home Page: http://www.amarincorp.com/

Vascepa (icosapent ethyl) Home Page: http://www.vascepa.com/savings.shtml

 

NASDAQ quote: http://www.nasdaq.com/symbol/amrn 

yahoo quote: http://finance.yahoo.com/q/h?s=AMRN 

AMRN company page on SA: http://seekingalpha.com/symbol/amrn?source=search_general&s=amrn


 

VASCEPA prescription spreadsheet: https://docs.google.com/spreadsheet/ccc?key=0AmTJU8mIVSebdGFUY253Y3BsTDBzbWRXSFVjbDZ0bHc#gid=12
Amarin Patent Spreadsheet :https://docs.google.com/spreadsheet/ccc?key=0Av_k_WaYce2IdDRKaWR1TmctcXVnMUhJQnlwbzEzeUE#gid=0

finviz page (headlines and basic stats); http://www.finviz.com/quote.ashx?t=AMRN&ty=c&ta=0&p=d

StreetInsider AMRN data page (headlines and analysts);  http://www.streetinsider.com/stock_lookup.php?LookUp=Get+Quote&q=amrn

 

Investor  Presentation (Apr'2013): http://files.shareholder.com/downloads/AMRN/2410758917x0x651653/CC47C992-CAF5-4A08-8DC6-F1DBF0AD5DB7/Amarin_Investor_Presentation_April_2013.pdf

Investor Presentation (Apr'2012):  http://www.amarincorp.com/downloads/investor-presentation.pdf

Amarin SEC filings: http://investor.amarincorp.com/sec.cfm

Vascepa FDA Orange Book page: http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=202057&Product_No=001&table1=OB_Rx
Vascepa CDER Medical / Clinical Review (July 25, 2012): http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202057Orig1s000MedR.pdf ;


FDA MAPP 5021.1 : http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ManualofPoliciesProcedures/UCM340273.pdf
(MANUAL OF POLICIES AND PROCEDURES, Naming of Drug Products Containing Salt Drug Substances)


~~~~~~~~~~~~~~~~~~~~~~
General:

Good & Bad Cholesterol - http://www.americanheart.org/presenter.jhtml?identifier=180

 

U.S. health system/CDC -  http://uk.reuters.com/article/2011/02/01/us-heart-usa-idUKTRE70N4JD20110201?feedType=RSS&feedName=healthNewsMolt

 

 

~~~~~~~~~~~~~~~~~~~~~~

General: 

The rationale for using EPA http://www.drsears.com/Portals/6/Documents/Understanding%20Eicosanoids.pdf 

 

Marine Trial hits all EndPoints - http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=533361

Marine Trial Conf Call (Nov '10):  - http://www.investorcalendar.com/IC/CEPage.asp?ID=162661

Transcript MARINE trial CC: http://files.shareholder.com/downloads/AMRN/1080589559x0x430674/E6D77DA6-F44C-405F-B479-9A5C31E7A6E3/AmarinCorporation112910_Transcript.pdf

Marine Trial Presentation - http://files.shareholder.com/downloads/AMRN/1080589559x0x423194/424D45B3-62CC-4A84-81D7-F5264EF82A11/MARINE_RESULTS_Nov_29_2010.pdf

Anchor Trial completes Enrollment - http://files.shareholder.com/downloads/AMRN/1080589559x0x428546/275b9676-c0cf-4bd0-a69b-e80e26433822/AMRN_News_2010_12_16_General_Releases.pdf

Anchor Trial hits all EndPoints - http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=569648

Anchor Trial Conf Call (Apr '11):  http://www.investorcalendar.com/IC/CEPage.asp?ID=164219

Additional Marine Trial Results:       http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=579260

 

Lovaza Label, etc

 

Excellent Blog Article featuring Lovaza data comparison - http://www.chasingthealpha.com/2010/11/amrn-look-at-tg-and-ldl-levels.html

 

http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-654_Omacor.cfm

 

http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021853_021654s016_omacor_toc.cfm

 

 

Various Trials, Statins/Lovaza etc:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813819/pdf/mayoclinproc_85_2_004.pdf

http://www.ncbi.nlm.nih.gov/pubmed/20877395

 

http://www.ncbi.nlm.nih.gov/pubmed/19002433

 

http://www.ncbi.nlm.nih.gov/pubmed/15250255

 

TriCor label, FIELD trial - http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021656s019lbl.pdf  

ACCORD trial - http://www.endocrinetoday.com/view.aspx?rid=61934 

                                                                    

Jelis Trial (Japan) - http://www.ccmdweb.org/dsl/middle.aspx?Slideid=2643&Catid=1043

transcript, ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE, 10/16/2013: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM376102.pdf
 




GOOGLE SPREADSHEET REGARDING PATENTS:
https://accounts.google.com/ServiceLogin?service=wise&passive=1209600&continue=https%3A%2F%2Fdocs.google.com%2Fspreadsheet%2Fccc%3Fkey%3D0Av_k_WaYce2IdDRKaWR1TmctcXVnMUhJQnlwbzEzeUE&followup=https%3A%2F%2Fdocs.google.com%2Fspreadsheet%2Fccc%3Fkey%3D0Av_k_WaYce2IdDRKaWR1TmctcXVnMUhJQnlwbzEzeUE&authuser=0#gid=0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMRN
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for AMRN
AMRN News: CapRock Research Initiates Analyst Coverage on Livedeal with $7.15 Price Target Issued By Small Cap Traders and 4 Brief Reports 02/19/2015 12:30:00 PM
AMRN News: EDISON EQUITY RESEARCH - AMARIN 02/17/2015 09:03:57 AM
AMRN News: Amended Statement of Ownership (sc 13g/a) 02/09/2015 01:36:02 PM
AMRN News: Current Report Filing (8-k) 02/03/2015 06:15:28 AM
AMRN News: Current Report Filing (8-k) 01/12/2015 08:01:49 AM
PostSubject
#30568  Sticky Note WRITE CONGRESS... WRITE THE FDA TODAY!!! go seek 07/11/14 07:31:47 PM
#4704  Sticky Note Everyone, Please get back on topic about AMRN, only. IH Admin [Linda] 04/22/13 09:21:30 AM
#43065   Amarin should have got NCE based on the marzan 02/28/15 03:33:36 PM
#43064   But I think that is inherent in all rosemountbomber 02/28/15 02:55:35 PM
#43063   You are right and we are all including marzan 02/28/15 02:46:24 PM
#43062   Two examples of China made OTC supplements that sts66 02/28/15 02:41:33 PM
#43061   You can keep repeating this until you turn rafunrafun 02/28/15 02:34:03 PM
#43060   Requesting that Congress order Secretary Burwell to make Biobillionair 02/28/15 02:29:07 PM
#43059   I have a problem with the statement.."naturally derived sts66 02/28/15 02:27:39 PM
#43058   If anyone follows NBA, Anthony Mason just passed rafunrafun 02/28/15 02:24:22 PM
#43057   Sad - if no NCE, no point of sts66 02/28/15 02:21:34 PM
#43056   India and China also have a sordid history sts66 02/28/15 02:11:56 PM
#43055   What is he doing? rafunrafun 02/28/15 02:11:06 PM
#43054   ggwpq: an active moiety is the chemical that ziploc_1 02/28/15 02:09:18 PM
#43053   For your scenario to come true, the interim sts66 02/28/15 02:05:07 PM
#43052   STS it's exactly implied by the FDA's own words: Biobillionair 02/28/15 02:03:31 PM
#43051   Wonderful logic by the FDA - "we've been sts66 02/28/15 02:00:43 PM
#43050   So you're saying that the FDA refused NCE sts66 02/28/15 01:56:15 PM
#43048   I agree but the fastest way to Anchor Biobillionair 02/28/15 01:50:01 PM
#43047   STS66 sometimes has a habit of posting his BioChica 02/28/15 01:46:12 PM
#43046   Pales in comparison to what ARNA got with sts66 02/28/15 01:46:04 PM
#43045   The infusion of cash from this partner does BioChica 02/28/15 01:42:03 PM
#43044   Thier argument is irrelevant, they admit that while Biobillionair 02/28/15 01:41:59 PM
#43043   <===================> China doesn't matter sts66 02/28/15 01:11:01 PM
#43042   We need a lawyer to file against the zmanindc 02/28/15 01:06:18 PM
#43041   I have a problem with the statement.."naturally derived epenephrine 02/28/15 01:01:55 PM
#43040   high teens royalties + milestones payments a staccani 02/28/15 12:50:19 PM
#43039   First of all I assumed 10% of the staccani 02/28/15 12:42:41 PM
#43038   concerning the amrn corp. regarding your post, 1bill 02/28/15 12:39:52 PM
#43037   BB, ppreciate your dd, but at some point rafunrafun 02/28/15 12:22:07 PM
#43036   So you make the comment, "REDUCE-IT changes nothing Bangtime 02/28/15 11:54:38 AM
#43035   After receiving this information we should... Biobillionair 02/28/15 11:54:28 AM
#43032   What in earth are you talking about "if rafunrafun 02/28/15 11:33:45 AM
#43031   Good article. I guess what I am couldbebetter 02/28/15 11:20:55 AM
#43030   GG, rosemountbomber 02/28/15 11:01:48 AM
#43029   Could, a number of reasons exist why rosemountbomber 02/28/15 10:58:24 AM
#43028   Correct. Amarin should at least explain this marzan 02/28/15 10:57:25 AM
#43027   I'm on board with you with my 70k shares. me33 02/28/15 10:53:58 AM
#43026   The FDA realized they made a dumb move Danburydude 02/28/15 10:53:12 AM
#43025   So, the evidence is clear, FDA acting 'Arbitrary BobWayne 02/28/15 10:51:04 AM
#43024   I cannot understand why as shareholders we can't zmanindc 02/28/15 10:50:15 AM
#43023   Correct. FDA's motive is clear. This marzan 02/28/15 10:30:21 AM
#43022   obese may be more susceptible to the cumulative zumantu 02/28/15 10:04:06 AM
#43021   Is AMRN going to make efficacy at interim couldbebetter 02/28/15 10:00:11 AM
#43020   "why should the FDA bother with the sNDA?" FishyFingers 02/28/15 09:24:13 AM
#43019   Zum, in the latest Amarin's press release on ggwpq 02/28/15 09:09:41 AM
#43018   HD, the following is what FDA used as ggwpq 02/28/15 09:03:50 AM
#43017   The FDA estimated that there would be 1065 bidmark 02/28/15 08:38:19 AM
#43016   I'd bet that AMRN & FDA have some rafunrafun 02/28/15 08:34:39 AM
#43015   Sure... Point is the same, Anchor is dead, zumantu 02/28/15 08:21:04 AM
#43014   FDA wouldn't say anything about interim. If they rafunrafun 02/28/15 08:19:04 AM
#43013   exactly, if R-I hits the numbers we think zumantu 02/28/15 07:59:24 AM
PostSubject